Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCSW) Amortization of Deferred Charges (2022 - 2025)

Historic Amortization of Deferred Charges for HeartSciences (HSCSW) over the last 3 years, with Q4 2025 value amounting to $263880.0.

  • HeartSciences' Amortization of Deferred Charges changed N/A to $263880.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $593730.0, marking a year-over-year change of. This contributed to the annual value of $285870.0 for FY2025, which is 17594.96% up from last year.
  • HeartSciences' Amortization of Deferred Charges amounted to $263880.0 in Q4 2025.
  • In the past 5 years, HeartSciences' Amortization of Deferred Charges registered a high of $263880.0 during Q4 2025, and its lowest value of $20719.0 during Q1 2024.
  • Its 3-year average for Amortization of Deferred Charges is $114085.0, with a median of $109950.0 in 2025.
  • Over the last 5 years, HeartSciences' Amortization of Deferred Charges had its largest YoY gain of 43067.23% in 2025, and its largest YoY loss of 43067.23% in 2025.
  • HeartSciences' Amortization of Deferred Charges (Quarter) stood at $61381.0 in 2022, then plummeted by 66.25% to $20719.0 in 2024, then surged by 1173.61% to $263880.0 in 2025.
  • Its Amortization of Deferred Charges stands at $263880.0 for Q4 2025, versus $109950.0 for Q3 2025 and $109950.0 for Q2 2025.